A biopharmaceutical company, primarily engaged in the discovery and development of a new therapeutic class of drugs for the treatment of cancer and other pathological conditions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This stock is a real sleeper.
I am a little worried about this stock. I have been watching it and recently read their newest SEC filing. They report that they have recently let some employees go and are now basically running on fumes with only enough assets to keep them afloat until July 2009. Even their report paints a picture that if their financial situation does not change drastically, they will go under.
It's a regular Rip Van Winkle.
I truly believe that the latest discovery of the effectiveness of the drug against yellow fever and dengue fever mean this stock will be moving up in a big way in the near future. It is a steal at the current price.
Wow another awesome test report against human HPV virus. We are on the verge of breakthrough.
Anybody have any recent information on this company?